1987
DOI: 10.1002/ajh.2830240109
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of cell cycle characteristics and course of the disease in ANLL

Abstract: The cell cycle characteristics of a newly diagnosed patient with acute nonlymphocytic leukemia (ANLL) were studied by using intravenous bromodeoxyuridine (BrdU) and our previously described "double-label" technique. The percentage of S-phase cells in the bone marrow (BM) biopsy were 25% compared to 7% from the simultaneously obtained BM aspirate. The duration of S-phase (Ts) was determined to be 4 hr and the total cell cycle time (Tc) was 16 hr. We demonstrated that the actual clinical course of this patient's… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1988
1988
1994
1994

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 15 publications
(1 citation statement)
references
References 16 publications
0
1
0
Order By: Relevance
“…In order to clarify the relation between Ag-NOR and the proliferative characteristics of leukemic cells, we stud ied the correlation in bone marrow leukemic cells between the number of Ag-NORs and the proportion in S-phase which is one of the most reliable indicators of cellular pro liferation and is related to the effect of therapy and prog nosis as well [22,23], To determine the in vivo S-phase size of leukemic cells, we have been using BrdU and its MoAb and staining by an immunohistochemical method which, in contrast to flow cytometry, made it possible to analyze cell kinetics in leukemias containing leukemic cells in low percentage.…”
Section: Discussionmentioning
confidence: 99%
“…In order to clarify the relation between Ag-NOR and the proliferative characteristics of leukemic cells, we stud ied the correlation in bone marrow leukemic cells between the number of Ag-NORs and the proportion in S-phase which is one of the most reliable indicators of cellular pro liferation and is related to the effect of therapy and prog nosis as well [22,23], To determine the in vivo S-phase size of leukemic cells, we have been using BrdU and its MoAb and staining by an immunohistochemical method which, in contrast to flow cytometry, made it possible to analyze cell kinetics in leukemias containing leukemic cells in low percentage.…”
Section: Discussionmentioning
confidence: 99%